Mary S. Silva

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants”.

Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.21.513237

N/A

0DataRank · unranked

5 citations

Kathryn T. Arrildt, Adam Zemła, Edmond Y. Lau, Fangqiang Zhu, Dante P. Ricci +38 more

A Computational Pipeline to Identify and Characterize Binding Sites and Interacting Chemotypes in SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.24.485222

N/A

0DataRank · unranked

1 citations

Jeffrey A. Drocco, Adam Zemła, Marisa W. Torres, Mary S. Silva, Jonathan Allen +1 more

A Computational Pipeline to Identify and Characterize Binding Sites and Interacting Chemotypes in SARS-CoV-2

ACS Omega(2023)10.1021/acsomega.3c01621

N/A

0DataRank · unranked

4 citations

Jeffrey A. Drocco, Adam Zemła, Marisa W. Torres, Mary S. Silva, Jonathan Allen +1 more

Computationally restoring the potency of a clinical antibody against Omicron

Nature(2024)10.1038/s41586-024-07385-1

N/A

0DataRank · unranked

49 citations

Kathryn T. Arrildt, Adam Zemła, Edmond Y. Lau, Fangqiang Zhu, Dante P. Ricci +71 more